Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World

doi:10.34172/ijhpm.2024.8295

Editorial

. 2024:13:8295.

doi: 10.34172/ijhpm.2024.8295. Epub 2024 Mar 5.

Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World

Jinmiao Lu¹, Xiaohua Ying², Zhiping Li¹

Affiliations

¹ Department of Clinical Pharmacy, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.
² NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China.

PMID: 39099520
PMCID: PMC11607532
DOI: 10.34172/ijhpm.2024.8295

Editorial

Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World

Jinmiao Lu et al. Int J Health Policy Manag. 2024.

. 2024:13:8295.

doi: 10.34172/ijhpm.2024.8295. Epub 2024 Mar 5.

Authors

Jinmiao Lu¹, Xiaohua Ying², Zhiping Li¹

Affiliations

¹ Department of Clinical Pharmacy, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China.
² NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China.

PMID: 39099520
PMCID: PMC11607532
DOI: 10.34172/ijhpm.2024.8295

No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors declare that they have no competing interests.

Figures

See this image and copyright information in PMC

References

1. Socal MP, Ahn K, Greene JA, Anderson GF. Competition and vulnerabilities in the global supply chain for US generic active pharmaceutical ingredients. Health Aff (Millwood) 2023;42(3):407–415. doi: 10.1377/hlthaff.2022.01120. - DOI - PubMed
1. Lu J, Ying X, Li Z. Value-based generic drug evaluation focus on Chinese real-world evidence. Int J Health Policy Manag. 2023;12(1):7970. doi: 10.34172/ijhpm.2023.7970. - DOI - PMC - PubMed
1. China National Health Development Research Center. Technical Guidelines for Comprehensive Clinical Evaluation of Cardiovascular, Antineoplastic, and Pediatric Drugs. http://www.nhei.cn/nhei/znfb/202206/c01d87a290664b01bf42a9dad769d69f.shtml.
1. Lu J, Wang G, Ying X, Li Z. A novel drug selection decision support model based on real-world medical data by the hybrid entropic weight TOPSIS method. Technol Health Care. 2023;31(2):691–703. doi: 10.3233/thc-220355. - DOI - PubMed
1. Sayah R, Awada S, Ismaiil L, Hatem G. Assessment of the differences between generic and biosimilar drugs: a brief literature review. J Generic Med. 2023;19(3):124–129. doi: 10.1177/17411343231157309. - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- PubMed Central

[1] Socal MP, Ahn K, Greene JA, Anderson GF. Competition and vulnerabilities in the global supply chain for US generic active pharmaceutical ingredients. Health Aff (Millwood) 2023;42(3):407–415. doi: 10.1377/hlthaff.2022.01120. - DOI - PubMed

[2] Socal MP, Ahn K, Greene JA, Anderson GF. Competition and vulnerabilities in the global supply chain for US generic active pharmaceutical ingredients. Health Aff (Millwood) 2023;42(3):407–415. doi: 10.1377/hlthaff.2022.01120. - DOI - PubMed

[3] Lu J, Ying X, Li Z. Value-based generic drug evaluation focus on Chinese real-world evidence. Int J Health Policy Manag. 2023;12(1):7970. doi: 10.34172/ijhpm.2023.7970. - DOI - PMC - PubMed

[4] Lu J, Ying X, Li Z. Value-based generic drug evaluation focus on Chinese real-world evidence. Int J Health Policy Manag. 2023;12(1):7970. doi: 10.34172/ijhpm.2023.7970. - DOI - PMC - PubMed

[5] China National Health Development Research Center. Technical Guidelines for Comprehensive Clinical Evaluation of Cardiovascular, Antineoplastic, and Pediatric Drugs. http://www.nhei.cn/nhei/znfb/202206/c01d87a290664b01bf42a9dad769d69f.shtml.

[6] China National Health Development Research Center. Technical Guidelines for Comprehensive Clinical Evaluation of Cardiovascular, Antineoplastic, and Pediatric Drugs. http://www.nhei.cn/nhei/znfb/202206/c01d87a290664b01bf42a9dad769d69f.shtml.

[7] Lu J, Wang G, Ying X, Li Z. A novel drug selection decision support model based on real-world medical data by the hybrid entropic weight TOPSIS method. Technol Health Care. 2023;31(2):691–703. doi: 10.3233/thc-220355. - DOI - PubMed

[8] Lu J, Wang G, Ying X, Li Z. A novel drug selection decision support model based on real-world medical data by the hybrid entropic weight TOPSIS method. Technol Health Care. 2023;31(2):691–703. doi: 10.3233/thc-220355. - DOI - PubMed

[9] Sayah R, Awada S, Ismaiil L, Hatem G. Assessment of the differences between generic and biosimilar drugs: a brief literature review. J Generic Med. 2023;19(3):124–129. doi: 10.1177/17411343231157309. - DOI

[10] Sayah R, Awada S, Ismaiil L, Hatem G. Assessment of the differences between generic and biosimilar drugs: a brief literature review. J Generic Med. 2023;19(3):124–129. doi: 10.1177/17411343231157309. - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World

Affiliations

Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources